InMode (NASDAQ:INMD) Stock Price Passes Above Two Hundred Day Moving Average – Time to Sell?

InMode Ltd. (NASDAQ:INMD) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $14.15 and traded as high as $14.66. InMode shares last traded at $14.54, with a volume of 409,945 shares trading hands.

Wall Street Analysts Forecast Growth

Several analysts have commented on INMD shares. Robert W. Baird reduced their price objective on InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a research note on Thursday, May 7th. Barclays set a $19.00 target price on shares of InMode and gave the company an “overweight” rating in a report on Thursday, May 7th. One research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $16.00.

InMode Trading Down 0.4%

The stock has a market cap of $835.76 million, a price-to-earnings ratio of 10.69 and a beta of 1.91. The firm’s 50 day moving average is $13.95 and its two-hundred day moving average is $14.15.

InMode (NASDAQ:INMD) last released its quarterly earnings results on Wednesday, May 6th. The healthcare company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.05). The firm had revenue of $82.02 million for the quarter, compared to analyst estimates of $79.84 million. InMode had a return on equity of 13.47% and a net margin of 23.27%.InMode’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the prior year, the business earned $0.31 earnings per share.

Institutional Investors Weigh In On InMode

Several hedge funds have recently made changes to their positions in INMD. Doma Perpetual Capital Management LLC lifted its position in InMode by 26.8% during the third quarter. Doma Perpetual Capital Management LLC now owns 2,838,431 shares of the healthcare company’s stock worth $42,293,000 after buying an additional 599,108 shares during the period. Topline Capital Management LLC grew its holdings in InMode by 2,296.8% in the 3rd quarter. Topline Capital Management LLC now owns 264,770 shares of the healthcare company’s stock valued at $3,945,000 after buying an additional 253,723 shares during the period. Ancient Art L.P. acquired a new position in shares of InMode during the 3rd quarter valued at about $14,254,000. DGS Capital Management LLC increased its stake in shares of InMode by 127.7% during the 4th quarter. DGS Capital Management LLC now owns 79,613 shares of the healthcare company’s stock valued at $1,170,000 after acquiring an additional 44,654 shares during the last quarter. Finally, State of Wyoming purchased a new position in shares of InMode during the 4th quarter worth about $624,000. Institutional investors and hedge funds own 68.04% of the company’s stock.

About InMode

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.